VBHI — Verde Bio Holdings Income Statement
0.000.00%
- $0.75m
- $0.88m
- $0.93m
Annual income statement for Verde Bio Holdings, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
| 2019 April 30th | 2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M | 
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | Final | 
| Revenue | |||||
| Total Revenue | 0 | 0 | 0.049 | 0.72 | 0.926 | 
| Cost of Revenue | |||||
| Gross Profit | 0 | — | -0.002 | — | — | 
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.028 | 0.549 | 2.85 | 3.87 | 2.57 | 
| Operating Profit | -0.028 | -0.549 | -2.8 | -3.15 | -1.64 | 
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.537 | -1.58 | -3.31 | -3.42 | -1.77 | 
| Net Income After Taxes | -0.537 | -1.58 | -3.31 | -3.42 | -1.77 | 
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.537 | -1.58 | -3.31 | -3.42 | -1.77 | 
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.537 | -1.58 | -3.31 | -3.44 | -1.86 | 
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.536 | -0.839 | -0.016 | -0.002 | -0.001 |